Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.

被引：0
|
作者：
Losk, Katya
Freedman, Rachel A.
Lin, Nancy U.
Golshan, Mehra
Lester, Susan
Pochebit, Stephen
Natsuhara, Kelsey
Camuso, Kristen
King, Tari A.
Bunnell, Craig A.
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[5] Brigham & Womens Faulkner Hosp, Boston, MA USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 08期
关键词：
D O I：
10.1200/JCO.2017.35.8_suppl.166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Implementation of Surgeon-Initiated Gene Expression Profile Testing (Oncotype DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation
    Losk, Katya
    Freedman, Rachel A.
    Lin, Nancy U.
    Golshan, Mehra
    Pochebit, Stephen M.
    Lester, Susan C.
    Natsuhara, Kelsey
    Camuso, Kristen
    King, Tari R.
    Bunnell, Craig A.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : E815 - E820
  • [2] Implementation of Surgeon-Initiated Gene Expression Profile Testing (Oncotype DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation (vol 13, pg e815, 2017)
    Losk, Katya
    Freedman, Rachel A.
    Lin, Nancy U.
    Golshan, Mehra
    Lester, Susan
    Pochebit, Stephen
    Natsuhara, Kelsey
    Camuso, Kristen
    King, Tari A.
    Bunnell, Craig A.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (11) : 776 - 776
  • [3] Implementation of an Oncotype DX® Ordering Protocol for Breast Cancer Patients Improves Care Coordination and Leads to Decreased Turn-around Times
    Poljak, Dijana
    Balla, Agnes
    Callas, Peter
    Sowden, Michelle
    LABORATORY INVESTIGATION, 2024, 104 (03) : S2024 - S2024
  • [4] Oncotype DX for Invasive Breast Carcinoma: Ordering of Test by Surgeon (Rather than Oncologist) can Reduce Turnaround Time
    Al-Baqali, Fatima
    Baum, Jordan
    Hoda, Syed
    MODERN PATHOLOGY, 2019, 32
  • [5] Oncotype DX for Invasive Breast Carcinoma: Ordering of Test by Surgeon (Rather than Oncologist) can Reduce Turnaround Time
    Al-Baqali, Fatima
    Baum, Jordan
    Hoda, Syed
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Megan C. Roberts
    Morris Weinberger
    Stacie B. Dusetzina
    Michaela A. Dinan
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Lisa A. Carey
    Stephanie B. Wheeler
    Breast Cancer Research and Treatment, 2015, 153 : 191 - 200
  • [7] Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
    Roberts, Megan C.
    Weinberger, Morris
    Dusetzina, Stacie B.
    Dinan, Michaela A.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    Carey, Lisa A.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 191 - 200
  • [8] Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
    Zekri, Jamal
    Al-Foheidi, Meteb
    Alata, Maaz
    Zabani, Reem
    Rasmy, Ayman
    BREAST CARE, 2020, 15 (06) : 642 - 647
  • [9] NSABP study confirms Oncotype DX predicts chemotherapy benefit in breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (07): : 789 - 790
  • [10] Factors associated with chemotherapy benefit in breast cancer patients with midrange Oncotype DX breast recurrence scores
    Cheng, Ran
    Wang, Zhongzhao
    Kong, Xiangyi
    Wang, Jing
    Fang, Yi
    Qi, Liqiang
    CANCER LETTERS, 2021, 503 : 213 - 219
12345